Bayer: Dynamic growth

The Bayer Group had a successful year in 2021, both operationally and strategically. “We posted substantial growth, strengthened our innovation pipeline and made progress toward our sustainability ...

Related Keywords

United States ,China ,California ,Russia ,America ,Fox Xpro ,Asia Pacific ,Werner Baumann ,Wolfgang Nickl ,Digestive Health ,Crop Science Division ,Vividion Therapeutics Inc ,Sales Of The Bayer Group ,Bayer Group ,Supreme Court ,Us Supreme Court ,Consumer Health ,Financial News ,Bio Revolution ,Crop Science ,Vividion Therapeutics ,Supervisory Board ,Annual Stockholder Meeting ,Latin America ,North America ,Soybean Seed ,Solicitor General ,Eastern Europe ,Bayer ,Fiscal Year ,